5402 J. Am. Chem. Soc., Vol. 123, No. 23, 2001
Janout et al.
1-palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine (POPC).15
Monolayer studies that have been carried out with one of these
conjugates in the absence, and in the presence, of POPC provide
insight into its likely conformation within a phospholipid bilayer.
TLC [silica, CHCl3/CH3OH/H2O, 103/27/2 (v/v/v)] to give 66.0 mg
(61%) of 3 having Rf 0.60 and H NMR (CD3OD) δ 8.22 (m, 2 H),
7.83 (m, 2 H), 7.56 (d, 2 H), 3.92 (s, 4 H), 3.78 (s, 4 H), 3.54 (m, 4
H), 3.35 (m, 4 H), 3.30 (m, 4 H), 3.10 (m, 4 H), 2.95 (m, 4 H), 0.90-
2.27 (m, 120 H), 0.90 (s, 12 H), 0.70 (s, 12 H).
1
Mixed Disulfide of GSH and N1,N3-Bis[dicholeamidospermidineyl]-
N2-(2-nitro-5-mercaptobenzamide) (1a). To a solution of 65.0 mg
(25.9 µmol) of 4 in 1.5 mL of methanol was added, dropwise, a solution
of 7.9 mg (25.9 µmol) of GSH in SHE buffer (8 mM NaCl, 2 mM
HEPES, 0.05 mM EDTA, pH 7.0) and the mixture stirred for 12 h at
room temperature. After concentration under reduced pressure (35 °C),
the product was dissolved in a minimum volume of CH3OH and purified
by preparative TLC [silica, CHCl3/CH3OH/H2O, 60/40/10 (v/v/v)] to
give 1a (53%) having Rf 0.37 and 1H NMR (CD3OD) δ 8.25 (m, 1 H),
7.84 (m, 1 H), 7.61 (d, 1 H), 4.69 (m, 1 H), 3.94 (s, 2 H), 3.78 (s, 2
H), 3.70 (m, 3 H), 3.35 (m, 2 H), 3.30 (m, 6 H), 3.15 (m, 2 H), 3.05
(m, 2 H), 2.50 (m, 2 H), 0.70-2.29 (m, 68 H), 0.69 (s, 6 H). HRMS
for C72H113N7O17S2 (MNa+): calcd 1434.7532, found 1434.7603.
Bis [N1,N3-Dicholeamidospermidineyl]-5,5′-dithiobis(2-nitro-
benzamide), Persulfate, Sodium Salt (5). To a solution of 41.0 mg
(18.5 µmol) of 4 in 1.20 mL of anhydrous DMF was added 143 mg
(0.9 mmol) of SO3‚Py and the mixture stirred at for 16 h at room
temperature. Removal of solvent under reduced pressure (55 °C, 10
Torr), followed by drying [23 °C, 2 h (1 Torr)], afforded a solid that
was redissolved in 2.50 mL of a saturated aqueous solution of NaHCO3.
The water was then removed under reduced pressure (10 Torr, 45°),
and the resulting solid extracted with 3 × 5 mL of CH3OH. The solution
was concentrated under reduced pressure to give 71 mg of crude
product, which was purified by preparative TLC (silica gel, CHCl3/
CH3OH/H2O, 34/28/8, v/v/v) to give 60 mg (94%) of 5 having Rf 0.60,
Experimental Section
General Methods. Unless stated otherwise, all reagents were
obtained from commercial sources and used without further purification.
1-Palmitoyl-2-oleoyl-sn-glycero-phosphocholine (POPC) was obtained
1
from Avanti Polar Lipids (Alabaster, AL). All H NMR spectra were
recorded on a Bruker 360 MHz instrument; chemical shifts are reported
in ppm and are referenced to residual solvent. The borate buffer that
was used in all experiments was composed of 0.1 M H3BO3, and 2
mM EDTA, where the pH was adjusted to 7.0 by use of 1 M NaOH.
N1,N3-Dicholeamidospermidine was prepared using procedures similar
to those previously described.12
Bis{3-O-[N-1,2,3-Benzotriazin-4(3H)-one]yl}-5,5′dithiobis-2-ni-
trobenzoate (BDTNB). To a suspension of 1.19 g (3.0 mmol) of 5,5′-
dithiobis(2-nitrobenzoic acid and 1.078 g (6.52 mmol) of 3-hydroxy-
1,2,3-benzotriazin-4H(3H)-one in 70 mL of CH2Cl2 was added 1.343
g (6.52 mmol) of dicyclohexylcarbodiimide. The heterogeneous mixture
was stirred at room temperature under a nitrogen atmosphere for 12 h,
and the solid separated by filtration and washed with CH2Cl2 (3 × 20
mL). The solid was dissolved in warm THF, and the solution then
concentrated to 30 mL under reduced pressure to allow for crystaliza-
tion, yielding 0.635 g (31%) of the desired diester having Rf 0.53
[CHCl3/acetone, 6/1 (v/v)], mp 213-214 °C dec, and 1H NMR (CDCl3)
δ 8.36 (dd, 1 H), 8.23 (m, 2 H), 8.18 (d, 1 H), 8.00 (dt, 1 H), 7.91 (dd,
1 H), 7.83 (dt, 1 H).
Mixed Disulfide Derived from 2-Nitro-5 mercapto-N,N-dimeth-
ylbenzamide and Glutathione (2). To a suspension of 54.0 mg (0.079
mmol) of BDTNB in 1 mL of anhydrous DMF was added 0.022 mL
of 40% dimethylamine/H2O (0.197 mmol) plus 50 µL of N,N-
diisopropyl-N-ethylamine (0.29 mmol). The reaction mixture was then
stirred for 3 h at room temperature and diluted with 20 mL of CH2Cl2.
Subsequent washing with 3 × 10 mL of saturated aqueous NaHCO3
and 3 × 20 mL of H2O, drying over Na2SO4, concentration under
reduced pressure, and purification by column chromatography (SiO2,
CHCl3/acetone, 6/1, v/v) afforded 35 mg (99%) of 5,5′-dithiobis(2-
nitro-N,N-dimethylbenzamide, having Rf 0.46 and 1H NMR (CDCl3) δ
8.12 (d, 2 H), 7.57 (d, 2 H), 7.40 (s, 2 H), 2.82-3.12 (d, 12 H).
To a solution of 20.0 mg of 5,5′-dithiobis(2-nitro-N,N-dimethyl-
benzamide) (44.4 µmol) in 1.4 mL of MeOH was slowly added a
solution of 13.6 mg of glutathione (44.3 µmol) in 0.4 mL of H2O and
the mixture then stirred under an argon atmosphere for 1 h at room
temperature. The mixture was then concentrated under reduced pressure
and the residue purified by flash chromatography (SiO2,CHCl3/MeOH/
H2O; 60/40/10; v/v/v) to give 8.1 mg (60%) of 2 having Rf 0.36 and
1H NMR (CD3OD) d 8.22 (d, 1 H), 7.82 (m, 1 H), 7.60 (s, 1 H), 4.66
(m, 1 H), 3.60-3.65 (m, 3 H), 2.80-3.11 (d, 6 H), 2.56 (m, 2 H), 2.14
(m, 2 H), 1.36 (m, 2 H).
N2,N2′-Bis[N1,N3-dicholeamidospermidineyl]-5,5′-dithiobis(2-ni-
trobenzamide) (4). To a stirred solution of 100 mg (0.108 mmol) of
N1,N3-dicholeamidospermidine (3) in 0.8 mL of anhydrous DMF and
0.1 mL of triethylamine was added 33.0 mg (0.048 mmol) of BDTNB.
The mixture was then stirred at room temperature under a nitrogen
atmosphere for 14 h, and the solvents removed under reduced pressure
(45 °C). The crude product was dissolved in 2 mL of methanol and
purified by precipitating into 35 mL of 10% NaHCO3. The solid was
separated, washed with water (3 × 20 mL), and purified by preparative
1
and H NMR (D2O) δ 8.28 (m, 2 H), 7.86 (m, 2 H), 7.46 (bs, 2 H),
4.64 (s, 4 H), 4.45 (s, 4 H), 4.18 (m, 4 H), 3.35 (m, 8 H), 3.16 (m, 8
H), 0.92-2.35 (m, 132 H), 0.73 (s, 12 H).
Mixed Disulfide of GSH and Persulfated N1,N3-Bis[dicholeamido-
spermidineyl]-N2-(2-nitro-5-mercaptobenzamide) (1b). To a stirred
solution of 50.0 mg (14.5 µmol) of 5 in 0.80 mL of MeOH was added
0.84 mL of an aqueous solution of 4.46 mg (14.5 µmol) of glutathione
(pH of which was adjusted to 7.16 by 1 N NaOH). After being stirred
for 60 min under an argon atmosphere, the solution was freeze-dried,
and the resulting solid was redisolved in 0.5 mL of MeOH/H2O (5/
2,v/v). The crude product was purified by preparative TLC (SiO2;
CHCl3/MeOH/H2O (34/28/8,v/v/v) under an argon atmosphere [solvents
were removed by a combination of rotatary evaporation (35 °C, 10
Torr) and freeze-drying] to give 21 mg (72%) of 1b with Rf 0.45 and
1H NMR (D2O) δ 8.26 (d, 1 H), 7.87 (d, 1 H), 7.53 (d, 1 H), 4.71 (m,
1 H), 4.68 (s, 2 H), 4.43 (s, 2 H), 3.91 (m, 2 H), 3.76 (t, 1 H), 3.50 (m,
2 H), 2.80-3.35 (m, 10 H), 2.42 (t, 2 H), 3.30-0.90 (m, 68 H), 0.71
(s, 6 H). Anal. Calcd for C72H107N7O35S8Na8‚10 H2O: C, 38.44; H,
5.60; N, 4.36. Found: C, 38.06; H, 5.52; N, 4.24.
Vesicles for Transport Experiments. Typically, 1.6 mL of a 25
mg/mL solution of POPC in chloroform was transferred to a Pyrex
test tube, and the solvent evaporated by rotating the tube under a stream
of nitrogen, resulting in a thin film of POPC. The last traces of solvent
were removed under reduced pressure (25°, 48 h, <0.2 Torr). To the
dried film was added 1.75 mL of a 1.20 mM solution of glutathione
(GSH) that was prepared in borate buffer, which had been adjusted to
pH 7.0 by addition of a few drops of 1 M NaOH. The mixture was
vortexed for 30 s, incubated at room temperature for 5 min, vortexed
for another 30 s, and incubated for 30 min, while being maintained
under an argon atmosphere. The dispersion was then subjected to 5
freeze/thaw cycles (-196 °C/30 °C), followed by extrusion through a
400 nm Nuclepore membrane (12 times) and a 200 nm membrane (15
times).
Gel Filtration Procedure. All gel filtrations were carried out via
minicolumn centrifugation using pre-packed Sephadex G-25, PD-10
(Pharmacia Biotech). Prior to use, the Sephadex G-25 was extensively
rinsed with borate buffer. Typically, 1.5 mL of the dispersion were gel
filtered (two times) using 4.0 g of Sephadex G-25 (fine), by expelling
the void volume of the column via centrifugation (4 min). To ensure
the complete removal of external GSH, the dispersion was dialyzed
using a bag made from SpectraPor #7 dialysis tubing (MWCO 50 000),
(15) A preliminary account of this work has previoiusly appeared: Janout,
V.; DiGiorgio, C.; Regen, S. L. J. Am. Chem. Soc. 2000, 122, 2671.